4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001415889-15-002218
CIK 0001411879operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:48 PM ET
Size
4.6 KB
Accession
0001415889-15-002218
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2015-06-26$0.12/sh+50$6→ 6,852,322 total
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 4:48 PM ET
- Size
- 4.6 KB